Rheumera

What Rheumera does

Rheumera, Inc. is a Washington, DC-based digital health company founded in 2023 that operates a mobile-first Remote Therapeutic Monitoring (RTM) platform for rheumatology. The platform consists of three product surfaces: a native iOS and Android patient app for daily patient-reported outcome (PRO) collection, flare logging, medication reminders, and trend visualization; a provider dashboard with AI-powered work queue prioritization, diagnosis-specific protocol management, and RTM billing documentation support; and a partner-facing module for pharmaceutical companies to deliver co-branded patient education, medication adherence programs, and patient support services. The platform is configured with 14+ diagnosis-specific PRO protocols covering conditions including rheumatoid arthritis, psoriatic arthritis, lupus, fibromyalgia, Sjögren's, ankylosing spondylitis, gout, PMR/GCA, myositis, systemic sclerosis, and others, combining validated instruments with physician-reviewed educational content.

The underlying technology stack includes HIPAA-compliant cloud infrastructure, opt-in data integration with Apple Health and Google Fit, and AI features focused on structured PRO analysis (auto-pinning escalating cases, generating AI summaries, suggesting replies, and detecting flare spikes). The company has collected 4+ million PROs year-to-date and reports a 73% 6-month patient retention rate and 85% medication adherence improvement among users.

Rheumera operates a B2B2C distribution model with three go-to-market motions: direct-to-consumer app downloads via iOS and Google Play stores (patients connect to clinics with a clinic code), B2B sales to rheumatology practices for RTM program launch, and a pharma channel partner program. Revenue is generated through two streams: (1) insurance-covered RTM services billed by providers using CPT codes 98975-98981 (covered by Medicare and most health plans), and (2) subscription-style partnerships with pharmaceutical companies for patient engagement and adherence programs. The company is privately held, appears bootstrapped with no disclosed funding rounds, and operates exclusively in the United States.

Name

Rheumera

Legal name

Rheumera, Inc.

Website

https://rheumera.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Rheumera is a Washington, DC-based digital health company (founded 2023) operating a mobile-first Remote Therapeutic Monitoring platform for rheumatology, enabling patients to log daily PROs, providers to bill CPT 98975-98981, and pharma partners to deliver adherence and education programs.

Ownership category

akta.pro rank

Product category

Remote Therapeutic Monitoring Software

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

akta.pro secondary industries

Rheumatology Telemedicine Platforms (HLALAGAG), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Remote patient monitoring
• Rheumatology care platform
• Patient-reported outcomes
• Chronic disease management
• Digital therapeutic monitoring

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Insurance Billing for RTM Services: Rheumera is a covered benefit under most health insurance plans including Medicare. Providers bill using CPT codes 98975-98981 for Remote Therapeutic Monitoring services. CPT 98975 covers setup and patient education (one-time), CPT 98977 covers device data collection for 16-30 days, CPT 98980 covers treatment management for first 20 minutes per month, and CPT 98981 covers each additional 20 minutes.
2. Pharma Partner Programs: Partnership model offering pharma companies patient engagement, medication adherence, education, and support services delivered through the Rheumera app. Programs include patient support services (hub/copay enrollment), de-identified insights, and co-branded educational modules.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Rheumera provides a mobile-first Remote Therapeutic Monitoring (RTM) platform for rheumatology, comprising a patient-facing iOS/Android app for daily symptom and medication tracking, a provider dashboard with AI-powered case prioritization and RTM billing support, and a partner module for pharmaceutical companies. The platform enables 14+ diagnosis-specific PRO protocols (RA, PsA, SLE, Fibromyalgia, etc.) with automated flare detection, HIPAA-compliant data handling, and documentation mapped to CPT codes 98975-98981.

Product overview

Rheumera is a mobile-first healthcare technology platform comprising a unified patient mobile application (iOS/Android), a provider dashboard with AI-powered work queue and RTM billing support, and a partner-facing module for patient engagement and education. The core patient app enables daily PRO tracking, flare logging, medication reminders, and trend visualization, while the provider dashboard aggregates patient data, supports diagnosis-specific protocols for 15 rheumatologic conditions, and enables RTM billing (CPT 98975–98981).

Differentiator

Problem solved

Functional benefit

Products and services

• Rheumera Patient App Native mobile application (iOS/Android) for patients to track pain, fatigue, function, and symptoms through daily PRO check-ins, log flares, view trends (7-day/30-day), manage medication reminders, access an education library reviewed by physicians, and export charts for clinic visits. Connects to a rheumatology clinic using a clinic code.
• Rheumera Provider Dashboard Physician and care team portal featuring a patient work queue, longitudinal PRO trend visualization, diagnosis-specific protocol management, AI-powered case prioritization, AI-generated summaries with suggested clinical replies, and RTM billing documentation support for CPT codes 98975-98981.
• Rheumera Partner Module Partner-facing module for pharmaceutical and healthcare organizations to deliver in-app patient education, medication adherence programs, care pathway orchestration, and co-branded content with clinical review capabilities. Provides access to de-identified cohort insights from Rheumera's patient base.

Quantifiable outcome

• 73% 6-month patient retention rate on the platform
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature7 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Omada Health: Omada Health is an established digital chronic care platform covering diabetes prevention, hypertension, and musculoskeletal conditions through coaching and connected devices. It is a comparable digital-first chronic disease platform with proven payer distribution and a broader but adjacent scope to Rheumera.
• Hinge Health: Hinge Health is a large digital musculoskeletal platform combining virtual PT, wearable sensors, and care teams for back, joint, and chronic pain. While broader than rheumatology, it is increasingly expanding into inflammatory arthritis and overlaps with Rheumera's musculoskeletal symptom population and PRO-based engagement model.
• WellDoc: WellDoc is an RPM and digital therapeutic company historically focused on diabetes and now expanding into additional chronic conditions with FDA-cleared products. It is a comparable chronic-care digital health platform with a longer regulatory and reimbursement track record than Rheumera.
• Sword Health: Sword Health is a digital musculoskeletal care provider offering AI-guided virtual physical therapy and clinician oversight. It competes for similar payer and employer budgets as Rheumera in the MSK/chronic pain space and represents a well-capitalized adjacent incumbent in the broader digital care category.
• DarioHealth: DarioHealth is a multi-condition digital chronic care platform spanning diabetes, hypertension, musculoskeletal, and behavioral health, with strong payer and employer distribution. It competes for the same RPM/CPT-reimbursed chronic care budgets as Rheumera and is expanding into rheumatology-adjacent conditions.

Direct peers

• CareSimple: CareSimple is a Remote Patient Monitoring and Remote Therapeutic Monitoring platform designed to enable physician practices to bill CPT 98975-98981 with minimal workflow disruption. It is a direct peer to Rheumera in the RTM billing infrastructure layer, though less specialty-specialized.
• Mymee: Mymee is a digital health company specializing in autoimmune disease management through personalized data-driven coaching and symptom tracking. It is highly comparable to Rheumera in its condition-specific focus and reliance on patient-reported outcomes rather than wearable device data.
• Aila Health: Aila Health is a digital care platform focused on autoimmune and rheumatologic conditions, offering symptom tracking, education, and care coordination. It is the most direct competitor to Rheumera, targeting the same patient and provider audience with similar mobile-first PRO workflows.

Emerging players

• Kaia Health: Kaia Health is a digital therapeutics company for MSK pain and COPD with app-based exercise, education, and symptom tracking. It overlaps with Rheumera in mobile-first chronic disease self-management and PRO collection, though its clinical focus is broader and less rheumatology-specialized.
• Vivante Health: Vivante Health is a digital digestive and inflammatory condition platform offering GI-focused symptom tracking, nutrition, and care coordination. It is comparable to Rheumera as a specialty-specific digital health company using PROs and digital engagement, though focused on GI rather than rheumatology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rheumera